Epstein Secrets

ll mails are also sent to our shared inbox [email protected] to avoid getting overlooked. This email is sent to you by Evalueserve on behalf of Deutsche Bankcont size=3> Diese email wurde Ihnen von Evalueserve im Auftrag der Deutschen Bank gesen=et For additional Deutsche Bank research, visit our web site: h

overlooked. This email is sent to you by Evalueserve on behalf of Deutsche Bankcont size=3> Diese email wurde Ihnen von Evalueserve im Auftrag der Deutschen Bank gesen=et For additional Deutsche Bank research, visit our web site: http://gm.db.com/equities Please refer to the disclaimer that applies to the re

weighted calculations. This makes our weighted avg. tax rate for 2015 at -21%. Every 100bps tax rate impacts 2015 EPS by 10c (1.3% our of '14 EPS). Generic Sustiva will benefit COGS over next three years. We model COGS of 20% in '14 vs. 12% in '16 Sustiva (a component of Atripla not made by GILD) is going gener

void getting overlooked. This email is sent to you by Evalueserve on behalf of Deutsche Bank Diese email wurde Ihnen von Evalueserve im Auftrag der Deutschen Bank gesendet For additional Deutsche Bank research, visit our web site: http://am.db.com/equities Please refer to the disclaimer that applies to the re

weighted calculations. This makes our weighted avg. tax rate for 2015 at -21%. Every 100bps tax rate impacts 2015 EPS by 10c (1.3% our of '14 EPS). Generic Sustiva will benefit COGS over next three years. We model COGS of 20% in '14 vs. 12% in '16 Sustiva (a component of Atripla not made by GILD) is going gener

erlooked. This email is sent to you by Evalueserve on behalf of Deutsche Bank<=ont size="3"> Diese email wurde Ihnen von Evalueserve im Auftrag der Deutschen Bank gesen=et 2 EFTA_R1_01758240 EFTA02581644 For additional Deutsche Bank research, visit our web site: http://gm.db.com/equities Please refer to t

eighted calculations. This makes our weighted avg. tax rate for 2015 at - 21%. Every 100bps tax rate impacts 2015 EPS by 10c (1.3% our of '14 EPS). Generic Sustiva will benefit COGS over next three years. We model COGS of 20% in '14 vs. 12% in '16 Sustiva (a component of Atripla not made by GILD) is going gener